Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe/532Ser haplotype

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3979-3987

  Dieude P ^a,b   Bouaziz, M ^c   Guedj, M ^c   Riemekasten, G ^d   Airo P ^e   Muller M ^f,g   Cusi, D ^h   Matucci Cerinic, M ⁱ   Melchers, I ^j   Koenig, W ^k   Salvi, E ^h   Wichmann, H E ^f,g   Cuomo, G ^l   Hachulla, E ^m   Diot, E ⁿ   Hunzelmann, N ^o   Caramaschi, P ^p   Mouthon, L ^a   Riccieri, V ^q   Distler, J ^r   Tarner, I ^s   Avouac, J ^a   Meyer, O ^a   Kahan, A ^a   Chiocchia, G ^t,u   Boileau, C ^v   Allanore, Y ^t,u   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e SPEDALI CIVILI   (Italy)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY HOSPITAL ULM   (Germany)

^l SECOND UNIVERSITY OF NAPLES   (Italy)

^m UNIV LILLE   (France)

ⁿ CHU BRETONNEAU   (France)

^o UNIVERSITY OF COLOGNE   (Germany)

^p UNIVERSITY HOSPITAL OF VERONA   (Italy)

^q SAPIENZA UNIVERSITY OF ROME   (Italy)

^r UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^s JUSTUS LIEBIG UNIVERSITY   (Germany)

^t INSTITUT COCHIN   (France)

^u université Paris Cité   (France)

^v LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; X CHROMOSOME;

ADULT; AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, X; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GERMANY; HAPLOTYPES; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; ITALY; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 82455198713     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30640     Document Type: Article

References (30)

1. Dieude P, Boileau C, Allanore Y,. Immunogenetics of systemic sclerosis. Autoimmun Rev 2011; 10: 282-90.
2. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD,. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001; 44: 1359-62. (Pubitemid 32537534)
3. Feghali-Bostwick C, Medsger TA Jr, Wright TM,. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003; 48: 1956-63. (Pubitemid 36828691)
4. Allanore Y, Dieude P, Boileau C,. Updating the genetics of systemic sclerosis. Curr Opin Rheumatol 2010; 22: 665-70.
5. Dieude P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E, et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 2009; 60: 3447-54.
6. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Airo P, et al. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis 2011; 70: 668-74.
7. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 2010; 69: 1958-64.
8. Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009; 106: 6256-61.
9. Eloranta ML, Franck-Larsson K, Lovgren T, Kalamajski S, Ronnblom A, Rubin K, et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 2010; 69: 1396-402.
10. Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y, et al. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010; 37: 1488-501.
11. Gottipati S, Rao NL, Fung-Leung WP,. IRAK1: a critical signaling mediator of innate immunity. Cell Signal 2008; 20: 269-76.
12. Li X, Commane M, Jiang Z, Stark GR,. IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci U S A 2001; 98: 4461-5. (Pubitemid 32294999)
13. Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB, et al. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol 2007; 82: 280-3. (Pubitemid 46686662)
14. Ishida R, Emi M, Ezura Y, Iwasaki H, Yoshida H, Suzuki T, et al. Association of a haplotype (196Phe/532Ser) in the interleukin-1-receptor- associated kinase (IRAK1) gene with low radial bone mineral density in two independent populations. J Bone Miner Res 2003; 18: 419-23. (Pubitemid 36241057)
15. Arcaroli J, Silva E, Maloney JP, He Q, Svetkauskaite D, Murphy JR, et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-κB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 2006; 173: 1335-41. (Pubitemid 43900707)
16. Liu G, Tsuruta Y, Gao Z, Park YJ, Abraham E,. Variant IL-1 receptor-associated kinase-1 mediates increased NF-κB activity. J Immunol 2007; 179: 4125-34.
17. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-5. (Pubitemid 18073738)
18. Valentini G, Matucci Cerinic M,. Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007; 25: 159-62.
19. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008; 47: 1185-92. (Pubitemid 352038224)
20. Wichmann HE, Gieger C, Illig T, for the MONICA/KORA Study Group. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67 Suppl 1: S26-30.
21. Holle R, Happich M, Lowel H, Wichmann HE, for the MONICA/KORA Study Group. KORA-a research platform for population based health research. Gesundheitswesen 2005; 67 Suppl 1: S19-25.
22. Steen VD, Medsger TA,. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4. (Pubitemid 46999798)
23. Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFβ and IFNγ distinguishes SSc phenotypes. PLoS One 2009; 4: e5903.
24. Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009; 60: 225-33.
25. Dieude P, Guedj M, Wipff J, Avouac J, Hachulla E, Diot E, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum 2008; 58: 2183-8. (Pubitemid 351988112)
26. Dieude P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 2009; 60: 2472-9.
27. Rao N, Nguyen S, Ngo K, Fung-Leung WP,. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol Cell Biol 2005; 25: 6521-32. (Pubitemid 41023227)
28. Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008; 3: e1727.
29. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-91. (Pubitemid 28248804)
30. Brooks WH,. X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010; 39: 20-9.